"Cost-Benefit Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.
| Descriptor ID |
D003362
|
| MeSH Number(s) |
N03.219.151.125
|
| Concept/Terms |
Cost-Benefit Analysis- Cost-Benefit Analysis
- Analyses, Cost-Benefit
- Analysis, Cost-Benefit
- Cost-Benefit Analyses
- Cost Benefit Analysis
- Analyses, Cost Benefit
- Analysis, Cost Benefit
- Cost Benefit Analyses
Cost-Utility Analysis- Cost-Utility Analysis
- Analyses, Cost-Utility
- Analysis, Cost-Utility
- Cost Utility Analysis
- Cost-Utility Analyses
Economic Evaluation- Economic Evaluation
- Economic Evaluations
- Evaluation, Economic
- Evaluations, Economic
Marginal Analysis- Marginal Analysis
- Analyses, Marginal
- Analysis, Marginal
- Marginal Analyses
Cost Benefit- Cost Benefit
- Costs and Benefits
- Benefits and Costs
|
Below are MeSH descriptors whose meaning is more general than "Cost-Benefit Analysis".
Below are MeSH descriptors whose meaning is more specific than "Cost-Benefit Analysis".
This graph shows the total number of publications written about "Cost-Benefit Analysis" by people in this website by year, and whether "Cost-Benefit Analysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 6 | 6 |
| 1998 | 0 | 7 | 7 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 9 | 9 |
| 2001 | 1 | 6 | 7 |
| 2002 | 0 | 7 | 7 |
| 2003 | 0 | 10 | 10 |
| 2004 | 1 | 7 | 8 |
| 2005 | 1 | 10 | 11 |
| 2006 | 0 | 11 | 11 |
| 2007 | 0 | 14 | 14 |
| 2008 | 0 | 10 | 10 |
| 2009 | 0 | 7 | 7 |
| 2010 | 0 | 12 | 12 |
| 2011 | 0 | 10 | 10 |
| 2012 | 0 | 19 | 19 |
| 2013 | 0 | 16 | 16 |
| 2014 | 4 | 10 | 14 |
| 2015 | 3 | 23 | 26 |
| 2016 | 3 | 15 | 18 |
| 2017 | 6 | 15 | 21 |
| 2018 | 4 | 16 | 20 |
| 2019 | 4 | 20 | 24 |
| 2020 | 5 | 19 | 24 |
| 2021 | 4 | 19 | 23 |
| 2022 | 1 | 5 | 6 |
| 2023 | 1 | 7 | 8 |
| 2024 | 6 | 6 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cost-Benefit Analysis" by people in Profiles.
-
Economic Value of Bronchoscopy Technologies that Improves Sensitivity for Malignancy for Peripheral Pulmonary Lesions. Ann Am Thorac Soc. 2024 Dec; 21(12):1759-1769.
-
The evolving role of multidisciplinary teams in optimizing non-muscle invasive bladder cancer care. Expert Rev Anticancer Ther. 2024 Dec; 24(12):1203-1208.
-
Impact of adherence on the cost-effectiveness of apixaban and rivaroxaban in stroke prevention among patients with atrial fibrillation in the United States. Expert Rev Pharmacoecon Outcomes Res. 2025 Jan; 25(1):63-70.
-
The utility of value frameworks in cost communications: making them real for patients. J Natl Cancer Inst. 2024 Sep 01; 116(9):1411-1413.
-
What Is the Economic Benefit of Annual COVID-19 Vaccination From the Adult Individual Perspective? J Infect Dis. 2024 Aug 16; 230(2):382-393.
-
A propensity score matched cost analysis of robotic versus open hepatectomy. HPB (Oxford). 2024 Nov; 26(11):1379-1386.
-
Cell and gene therapy accessibility. Science. 2024 Aug 02; 385(6708):475.
-
The Street Medicine Auto-refraction Technology Study: A Model for Screening and Treating Refractive Error in Persons Experiencing Homelessness. Am J Ophthalmol. 2025 Feb; 270:183-191.
-
The Cost-Effectiveness of Omalizumab for Treatment of Food Allergy. J Allergy Clin Immunol Pract. 2024 Sep; 12(9):2481-2489.e1.
-
Cost-effectiveness and threshold analysis of deep brain stimulation vs. treatment-as-usual for treatment-resistant depression. Transl Psychiatry. 2024 Jun 07; 14(1):243.